All News

Gazyva may become a standard treatment for older, sicker patient with CLL.

Patients with multiple myeloma fare better with continuous Revlimid (lenalidomide).

The Memory and Attention Adaptation Training (MAAT) program was designed to improve the quality of life and function of cancer survivors who are experiencing post-therapy cognitive issues.

Brain cancer researchers and advocates join resources to help tackle this rare and aggressive malignancy.

Patients battling cancer get financial assistance from friends, family, social media and non-profit organizations.